← Back to Clinical Trials
Recruiting NCT06745141

NCT06745141 Myocardial Infarction and Periodontitis: Periodontal Health Intervention.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06745141
Status Recruiting
Phase
Sponsor Shanghai 10th People's Hospital
Condition Acute Myocardial Infarction (AMI)
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2020-12-01
Primary Completion 2025-06-30

Eligibility & Interventions

Sex All sexes
Min Age 30 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Periodontal surgery

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2020-12-01 with a primary completion date of 2025-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to establish a shared database of acute myocardial infarction patients with periodontitis, to clarify the clinical benefits of periodontitis intervention on acute myocardial infarction patients through simulated RCT study, and to establish a high-level database of acute myocardial infarction patients with periodontitis, so as to promote the application of oral health intervention in clinical practice.

Eligibility Criteria

Inclusion Criteria: * 1)Patients diagnosed with ST-segment elevation myocardial infarction (STEMI). 2)Patients with severe periodontal disease, defined as: * 5 teeth with clinical attachment loss (CAL) ≥ 4 mm. * Subgingival probing depth (PD) ≥ 6 mm. ③≥ 8 teeth with gingival bleeding on probing (BOP). 3)Age ≥30 years. 4)Written informed consent provided. Exclusion Criteria: * 1\) under 30 years old; 2) HIV positive, chronic inflammation, tumor disease, drug dependence, use of anticonvulsants, use of immunosuppressive agents, pregnancy, and lactation; 3) significant tooth loss (number of remaining teeth \< 8); 4) long hospital stay (\>10 days), new myocardial infarction before randomization, and stent thrombosis; 5) Refusal to sign informed consent.

Contact & Investigator

Central Contact

Jiawen Wu

✉ chloewuu@foxmail.com

📞 86+17717070557

Frequently Asked Questions

Who can join the NCT06745141 clinical trial?

This trial is open to participants of all sexes, aged 30 Years or older, studying Acute Myocardial Infarction (AMI). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06745141 currently recruiting?

Yes, NCT06745141 is actively recruiting participants. Contact the research team at chloewuu@foxmail.com for enrollment information.

Where is the NCT06745141 trial being conducted?

This trial is being conducted at Shanghai, China.

Who is sponsoring the NCT06745141 clinical trial?

NCT06745141 is sponsored by Shanghai 10th People's Hospital. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology